Industry Insight
Discovery Technology
Analytical Laboratory Technology
Delivery Systems
Ingredients, Formulation and Finishing
View our other publications with free access to extensive archives
  To view this article:
Existing subscribers please log in:
   Or select

Or become a subscriber

Click here to view
our current issue


The Need for Digital Marketplaces

The cost of drug development has grown steadily and significantly over the past 40 years. As such, the business model for drug discovery and development is increasingly predicated on recouping costs barely manageable even for affluent nations. In an effort to combat this trend, various stakeholders in the drug discovery ecosystem − academia, industry, foundations, governments, and regulators − have been identifying and exploring novel models based on the collaboration and distribution of risk that provide new schemes for incentivising and rewarding drug discovery.

Liesl Eichholz at Molecule (July 2019)

Keywords: financial innovation pharma IP IP securitisation Digital market

    View full article    |    Back to Discovery Technology section

Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPT © 2021 Innovations in Pharmaceutical Technology | Terms and Conditions | | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |